Although the combination of CA19-9, OPN, and CHI3L1 improves the diagnostic accuracy compared to CA19-9 alone, our study was limited to patients with locally advanced pancreatic cancer. This evidence concerns the gene CHI3L1 and pancreatic neoplasm.